Reduced pathogenicity of a Candida albicans MAP kinase phosphatase (CPP1) mutant in the murine mastiffs model

APMIS

Volumn 106, Issue 11, 1998, Pages 1049-1055

  Guhad, Faisal A ^a   Csank, Csilla ^c,d   Jensen, Henrik E ^b   Thomas, David Y ^c,e   Whiteway, Malcolm ^c,e   Hau, Jann ^a,f  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

Animal model; Candida albicans; Mitogen activated protein kinase; Null mutants; Pathogenicity; Reintegrated strains; Virulence factors

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; FEMALE; FUNGUS MUTATION; GENE DELETION; GENETIC RECOMBINATION; HISTOPATHOLOGY; MALE; MASTITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; VIRULENCE;

EID: 0032438395     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1998.tb00257.x     Document Type: Article

References (20)

1. Cobb, M. H. & Goldsmith, E. J.: How MAP kinases are regulated. J. Biol. Chem 270: 14843-14846, 1995.
2. Csank, C., Makris, C., Meloche, S., Schröppel, K., Röllinghoff, M., Dignard, D., Thomas, D. Y. & Whitemay, M.: Derepressed hyphal growth and reduced virulence in a VH1 family-related protein phosphatase mutant of the human pathogen Candida albicans. Mol. Biol. Cell 8: 2539-2551, 1997.
3. Diez-Orejas, R., Molero, G., Navarro-Garcia, F., Pla, J., Nombela, C. & Sanchez-Perez, M.: Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis. Infect. Immun. 65: 833-837, 1997.
4. Ghannoum,M. A., Spellberg, B., Saporito Irwin, S. M. & Fonzi, W. A.: Reduced virulence of Candida albicans PHR1 mutants. Infect. Immun. 63: 4528-530, 1995.
5. Gillum, A., Tsay, E. & Kirsch, D.: Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198: 179-182, 1984.
6. Githad, F. A., Jensen, H. E., Aalbaek, B., Rycroft, A. & Hau, J.: A murine model for the study of mycotic mastitis. J. Comp. Pathol. 113: 315-325, 1995.
7. Hostetter, M. K.: Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin. Microbiol. Rev 7: 29-42, 1994.
8. Jensen, H. E., Aalbaek, B., Lind, P., Frandsen, P. U. & Krogh, H. V.: Enzyme immunohistochemistry with mono- and polyclonal antibodies in the pathological diagnosis of systemic bovine mycosis. APMIS 101: 505-516, 1994.
9. Jensen, H. E. & Schonheyder, H.: Immunofluorescence staining of hyphae in the histopathological diagnosis of mycoses in cattle. J. Med. Vet. Mycol. 27: 33-44, 1989.
10. Köhler, J. R. & Fink, G. R.: Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. Proc. Natl. Acad. Sci. USA 93: 13223-13228, 1996.
11. Leberer, E., Harcus, D., Broadbent, I., Clark, K., Dignard, D., Ziegelbauer, K., Schmidt, A., Gow, N., Brown, A. & Thomas, D.: Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc. Natl. Acad. Sci. USA 93: 13217-13222, 1996.
12. Leberer, E., Ziegelbauer, K., Schmidt, A., Harcus, D., Dignard, D., Ash. J., Johnson, L. & Thomas, D. Y.: Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p. Curr. Biol. 7: 539-546, 1997.
13. Liu, H., Köhler, J. & Fink, G. R.: Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266: 1723-1726, 1994.
14. Lo, H.-J., Köhler, J. R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A. & Fink, G. R.: Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949, 1997.
15. Maresca, B.: Unraveling the secrets of Histoplasma capsulatum. A model to study morphogenic adaptation during parasite/host interaction. Verh. K. Acad. Geneeskd. Belg. 57: 133-156, 1995.
16. Sarthy, A. V., McGonigal, T., Coen, M., Frost, D. J., Meulbroek, J. A. & Goldman, R. C.: Phenotype in Candida albicans of a disruption of the Gb12 gene encoding a 1,3-beta-glycosyltransferase. Microbiology 143: 367-376, 1997.
17. Scherer, S. & Magee, P. T.: Genetics of Candida albicans. Microbiol. Rev 54: 226-241, 1990.
18. Shepherd, M. G.: Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infection. Infect. Immun. 50: 541-544, 1985.
19. Stoldt, V. R., Sonneborn, A., Leuker, C. E. & Ernst, J. F.: Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 16: 1982-1991, 1997.
20. Zao, X. J., McElhaney-Feser, G. E., Sheridan, M. J., Broedel, S. E. Jr. & Cihlar, R. L.: Avirulence of Candida albicans FAS2 mutants in a mouse model of systemic candidiasis. Infect. Immun. 65: 829-832: 1997.